As with SST2A, significantly better outcomes were also seen in patients with CgA-positive neoplasms compared to CgA-negative tumors (PT plus MTS, PT and MTS separately: log-rank test: p < 0.001; all other cases log-rank test: p < 0.020) (Fig. 5B). Here, CGA is linked to neoplasm.